Cytori Therapeutics, Inc. (CYTX) is falling in the market today. The stock, focused in the biotechnology industry, is currently priced at $0.24 after heading down -5.66% so far today. In terms of biotech stocks, there are quite a few factors that have the potential to generate movement in the market. Cytori Therapeutics, Inc. markets its products to hospitals, clinics, tissue banks, and stem cell banking companies through direct sales reps, distributors, and partners worldwide. The company was founded in 1996 and is headquartered in San Diego, California. Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Get breaking news and analysis on Plus Therapeutics, Inc. (PSTV) stock, price quote and chart, trading and investing tools. 1 Wall Street analysts have issued ratings and price targets for Cytori Therapeutics in the last 12 months. There are currently 1 hold rating for the stock, resulting Cytori Therapeutics, Inc. (CYTX) is falling in the market today. The stock, focused in the biotechnology industry, is currently priced at $0.24 after heading down -5.66% so far today. In terms of biotech stocks, there are quite a few factors that have the potential to generate movement in the market. Cytori Therapeutics, Inc. markets its products to hospitals, clinics, tissue banks, and stem cell banking companies through direct sales reps, distributors, and partners worldwide. The company was founded in 1996 and is headquartered in San Diego, California.

View detailed financial information, real-time news, videos, quotes and analysis on Cytori Therapeutics Inc. (NASDAQ:CYTX). Explore commentary on Cytori Therapeutics Inc. and hear what the experts at TheStreet are saying about CYTX.

Past 30 Days – The return on investment from Cytori Therapeutics, Inc. throughout the last 30 days has been -11.56%. Quarterly – Over the last quarter, the stock has generated a return that comes to 4.81%; Past 6 Months – In the previous 6 months, investors have seen a change of -15.52% from the company. 4/11/2017 · Shares of Cytori Therapeutics Inc. cytx plunged 34% toward a record low in early-morning Tuesday, after the developer of burn treatments priced a stock offering at a deep discount. The pricing comes a day after the stock soared 26% as the company received Food and Drug Administration approval for its burn clinical trial. 10/6/2017 · Cytori Therapeutics, Inc - CYTX Stock Chart Technical Analysis for 10-06-17 ClayTrader does a quick stock chart review on Cytori Therapeutics, Cytori Therapeutics historical price data and CYTX charts. Free real-time prices, trades, and chat. Cytori Therapeutics (CYTX) stock price, charts, trades & the US's most popular discussion forums. The latest closing stock price for Cytori Therapeutics Inc as of December 27, 2019 is 2.49. The all-time high Cytori Therapeutics Inc stock closing price was 19.25 on August 28, 2019. The Cytori Therapeutics Inc 52-week high stock price is 22.89, which is 819.3% above the current share price. Infórmese de las cotizaciones del índice NASDAQ y obtenga información actualizada sobre sus valores, recomendaciones, análisis e histórico. Let our Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly analyze any stock, futures or forex market for you. It’s free, It’s informative, It’s on the money. View our complimentary trend analysis for Cytori Therapeutics, Inc (CYTX) now.

Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar. Cytori Therapeutics (CYTX) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. AUSTIN, Texas, July 29, 2019 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced that the Company has officially changed its name from “Cytori Therapeutics, Inc.” to “Plus Therapeutics, Inc.” and the ticker symbol for the Company’s common stock on the Nasdaq Capital Market will change from “CYTX” to “PSTV”.

Past 30 Days – The return on investment from Cytori Therapeutics, Inc. throughout the last 30 days has been -11.56%. Quarterly – Over the last quarter, the stock has generated a return that comes to 4.81%; Past 6 Months – In the previous 6 months, investors have seen a change of -15.52% from the company.

What's going on at Cytori Therapeutics (NASDAQ:CYTX)? View breaking news headlines for CYTX stock from trusted media outlets at MarketBeat. Cytori Therapeutics, Inc., of the United States, is a pharmaceutical company, based in San Diego. The company develops and manufactures medical devices that enable the therapeutic use of the adult stem and regenerative cells naturally found within adipose (fat) tissue. 3/8/2018 · Over the past 90 days, analysts have adjusted their estimates higher for EPS and revenues. The popular rating by analysts on Cytori Therapeutics stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days. Conference Call. Don't be surprised to see the stock move on comments made during its conference call. CYTX Stock Performance. Cytori Therapeutics Inc. (NASDAQ:CYTX) is currently trading in a downtrend, after reporting a third-quarter net loss that appears to have spooked investors. The therapeutics company focused on regenerative and oncologic therapies has underperformed the overall industry this year. Cytori Therapeutics, Inc, San Diego. 1.7K likes. Cytori is developing and commercializing cell therapies and nanomedicines for significant unmet medical

Past 30 Days – The return on investment from Cytori Therapeutics, Inc. throughout the last 30 days has been -11.56%. Quarterly – Over the last quarter, the stock has generated a return that comes to 4.81%; Past 6 Months – In the previous 6 months, investors have seen a change of -15.52% from the company.

Past 30 Days – The return on investment from Cytori Therapeutics, Inc. throughout the last 30 days has been -11.56%. Quarterly – Over the last quarter, the stock has generated a return that comes to 4.81%; Past 6 Months – In the previous 6 months, investors have seen a change of -15.52% from the company. 4/11/2017 · Shares of Cytori Therapeutics Inc. cytx plunged 34% toward a record low in early-morning Tuesday, after the developer of burn treatments priced a stock offering at a deep discount. The pricing comes a day after the stock soared 26% as the company received Food and Drug Administration approval for its burn clinical trial. 10/6/2017 · Cytori Therapeutics, Inc - CYTX Stock Chart Technical Analysis for 10-06-17 ClayTrader does a quick stock chart review on Cytori Therapeutics, Cytori Therapeutics historical price data and CYTX charts. Free real-time prices, trades, and chat. Cytori Therapeutics (CYTX) stock price, charts, trades & the US's most popular discussion forums. The latest closing stock price for Cytori Therapeutics Inc as of December 27, 2019 is 2.49. The all-time high Cytori Therapeutics Inc stock closing price was 19.25 on August 28, 2019. The Cytori Therapeutics Inc 52-week high stock price is 22.89, which is 819.3% above the current share price. Infórmese de las cotizaciones del índice NASDAQ y obtenga información actualizada sobre sus valores, recomendaciones, análisis e histórico.

Plus Therapeutics, Inc., formerly Cytori Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on developing treatments for patients battling cancer. The Company provides nanotechnology platform to reformulate and improve workhorse chemotherapeutics to provide We are driven by the pursuit of safe and effective medical devices that improve the health and well-being of people. Cytori Therapeutics Inc (NASDAQ: CYTX) is gaining big in the market early on this morning, with gains of more than 30%. The gains come after the company provided a regulatory update with regard to ATI-1123. Here’s what’s happening: Stop wasting your time!